Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
244 | 3 | IMMUNOLOGY//PHAGE DISPLAY//BIOSIMILAR | 47231 |
1263 | 2 | PHAGE DISPLAY//CATALYTIC ANTIBODIES//BISPECIFIC ANTIBODY | 9152 |
4756 | 1 | CANONICAL STRUCTURES//HUMANIZATION//ANTIBODY ENGINEERING | 1759 |
5723 | 1 | PHAGE DISPLAY//MIMOTOPE//LANDSCAPE PHAGE | 1614 |
6417 | 1 | PHAGE DISPLAY//ANTIBODY LIBRARY//SCFV | 1515 |
8174 | 1 | CATALYTIC ANTIBODIES//ABZYME//CHEM IMMUNOL THER EUT | 1308 |
8446 | 1 | BISPECIFIC ANTIBODY//BISPECIFIC ANTIBODIES//BISPECIFIC | 1283 |
14033 | 1 | NANOBODY//SINGLE DOMAIN ANTIBODY//VHH | 827 |
21184 | 1 | REPEAT PROTEIN//GANKYRIN//ANKYRIN REPEAT | 453 |
26151 | 1 | INTRABODY//INTRACELLULAR ANTIBODIES//INTRACELLULAR IMMUNIZATION | 283 |
35594 | 1 | KILLERRED//MINISOG//PL FUNDAMENTAL MED | 110 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PHAGE DISPLAY | authKW | 1409645 | 12% | 39% | 1061 |
2 | CATALYTIC ANTIBODIES | authKW | 776790 | 3% | 78% | 289 |
3 | BISPECIFIC ANTIBODY | authKW | 372684 | 2% | 56% | 195 |
4 | SINGLE DOMAIN ANTIBODY | authKW | 363311 | 2% | 76% | 139 |
5 | ANTIBODY ENGINEERING | authKW | 359985 | 2% | 46% | 226 |
6 | NANOBODY | authKW | 356219 | 2% | 58% | 178 |
7 | ABZYME | authKW | 284196 | 1% | 88% | 94 |
8 | SCFV | authKW | 255737 | 3% | 32% | 234 |
9 | ANTIBODY LIBRARY | authKW | 202116 | 1% | 69% | 85 |
10 | SINGLE CHAIN FV | authKW | 192719 | 1% | 46% | 123 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 23282 | 43% | 0% | 3914 |
2 | Biochemical Research Methods | 13831 | 14% | 0% | 1247 |
3 | Immunology | 12636 | 19% | 0% | 1736 |
4 | Biotechnology & Applied Microbiology | 7754 | 14% | 0% | 1237 |
5 | Biophysics | 3811 | 8% | 0% | 762 |
6 | Medicine, Research & Experimental | 1355 | 6% | 0% | 526 |
7 | Oncology | 1347 | 8% | 0% | 771 |
8 | Cell Biology | 621 | 6% | 0% | 580 |
9 | Chemistry, Multidisciplinary | 226 | 7% | 0% | 598 |
10 | Virology | 160 | 2% | 0% | 141 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CHEM IMMUNOL THER EUT | 44048 | 0% | 80% | 16 |
2 | IG THER Y CO | 27876 | 0% | 90% | 9 |
3 | LIFE SCI BIOMOL ENGN | 26428 | 0% | 59% | 13 |
4 | MINIST PUBL HLTH RUSSIAN FEDERAT | 23254 | 0% | 52% | 13 |
5 | PROT ENGN ANTIBODY TECHNOL | 23128 | 0% | 61% | 11 |
6 | PHAGE THER Y GRP | 20651 | 0% | 100% | 6 |
7 | CELLULAIRE MOL IMMUNOL | 20020 | 0% | 73% | 8 |
8 | LARGE MOL | 19695 | 0% | 30% | 19 |
9 | CHEM BIOL FUNDAMENTAL MED | 19640 | 1% | 8% | 74 |
10 | CLIN COOPERAT GRP BISPECIF ANTIBODIES | 17209 | 0% | 100% | 5 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MABS | 62216 | 1% | 15% | 120 |
2 | PROTEIN ENGINEERING DESIGN & SELECTION | 55417 | 1% | 12% | 133 |
3 | PORTLAND PRESS PROCEEDINGS | 42941 | 0% | 39% | 32 |
4 | JOURNAL OF IMMUNOLOGICAL METHODS | 37940 | 4% | 3% | 329 |
5 | JOURNAL OF MOLECULAR RECOGNITION | 23753 | 1% | 7% | 94 |
6 | MOLECULAR IMMUNOLOGY | 23143 | 2% | 3% | 221 |
7 | JOURNAL OF MOLECULAR BIOLOGY | 21816 | 4% | 2% | 390 |
8 | PROTEIN ENGINEERING | 19602 | 1% | 5% | 114 |
9 | IMMUNOTECHNOLOGY | 12039 | 0% | 50% | 7 |
10 | COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING | 4790 | 0% | 3% | 44 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHAGE DISPLAY | 1409645 | 12% | 39% | 1061 | Search PHAGE+DISPLAY | Search PHAGE+DISPLAY |
2 | CATALYTIC ANTIBODIES | 776790 | 3% | 78% | 289 | Search CATALYTIC+ANTIBODIES | Search CATALYTIC+ANTIBODIES |
3 | BISPECIFIC ANTIBODY | 372684 | 2% | 56% | 195 | Search BISPECIFIC+ANTIBODY | Search BISPECIFIC+ANTIBODY |
4 | SINGLE DOMAIN ANTIBODY | 363311 | 2% | 76% | 139 | Search SINGLE+DOMAIN+ANTIBODY | Search SINGLE+DOMAIN+ANTIBODY |
5 | ANTIBODY ENGINEERING | 359985 | 2% | 46% | 226 | Search ANTIBODY+ENGINEERING | Search ANTIBODY+ENGINEERING |
6 | NANOBODY | 356219 | 2% | 58% | 178 | Search NANOBODY | Search NANOBODY |
7 | ABZYME | 284196 | 1% | 88% | 94 | Search ABZYME | Search ABZYME |
8 | SCFV | 255737 | 3% | 32% | 234 | Search SCFV | Search SCFV |
9 | ANTIBODY LIBRARY | 202116 | 1% | 69% | 85 | Search ANTIBODY+LIBRARY | Search ANTIBODY+LIBRARY |
10 | SINGLE CHAIN FV | 192719 | 1% | 46% | 123 | Search SINGLE+CHAIN+FV | Search SINGLE+CHAIN+FV |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |